132 related articles for article (PubMed ID: 38751175)
1. Clinical versus Histological Assessment of Basal Cell Carcinoma Subtype and Thickness of Tumours Selected for Photodynamic Therapy.
Mørk E; Mjønes P; Foss OA; Mørk C; Bachmann IM; Kroon S; Dotterud LK; Helsing P; Vatne Ø; Christensen E
Acta Derm Venereol; 2024 May; 104():adv18308. PubMed ID: 38751175
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of recurrence after photodynamic therapy with topical methylaminolaevulinate for 157 basal cell carcinomas in 90 patients.
Lindberg-Larsen R; Sølvsten H; Kragballe K
Acta Derm Venereol; 2012 Mar; 92(2):144-7. PubMed ID: 21918794
[TBL] [Abstract][Full Text] [Related]
3. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
Itkin A; Gilchrest BA
Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
[TBL] [Abstract][Full Text] [Related]
4. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW
J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596
[TBL] [Abstract][Full Text] [Related]
5. Topical photodynamic therapy in the treatment of basal cell carcinoma in Singaporean Chinese patients.
Chia HY; Koh SL; Theng TS; Chong WS
Indian J Dermatol Venereol Leprol; 2015; 81(2):151-4. PubMed ID: 25751331
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion.
Hürlimann AF; Hänggi G; Panizzon RG
Dermatology; 1998; 197(3):248-54. PubMed ID: 9812030
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
8. Pre-treatment evaluation of basal cell carcinoma for photodynamic therapy: comparative measurement of tumour thickness in punch biopsy and excision specimens.
Christensen E; Mjønes P; Foss OA; Rørdam OM; Skogvoll E
Acta Derm Venereol; 2011 Oct; 91(6):651-4. PubMed ID: 21681364
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response.
Fantini F; Greco A; Del Giovane C; Cesinaro AM; Venturini M; Zane C; Surrenti T; Peris K; Calzavara-Pinton PG
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):896-901. PubMed ID: 21054566
[TBL] [Abstract][Full Text] [Related]
10. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.
Szeimies RM
Dermatol Clin; 2007 Jan; 25(1):89-94. PubMed ID: 17126746
[TBL] [Abstract][Full Text] [Related]
11. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage.
Soler AM; Warloe T; Berner A; Giercksky KE
Br J Dermatol; 2001 Sep; 145(3):467-71. PubMed ID: 11531838
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy in the management of basal cell carcinoma: Retrospective evaluation of outcome.
Jerjes W; Hamdoon Z; Hopper C
Photodiagnosis Photodyn Ther; 2017 Sep; 19():22-27. PubMed ID: 28442314
[TBL] [Abstract][Full Text] [Related]
14. Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department.
Cabete J; Rafael M; Cravo M; Moura C; Sachse F; Pecegueiro M
An Bras Dermatol; 2015; 90(6):846-50. PubMed ID: 26734866
[TBL] [Abstract][Full Text] [Related]
15. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
[TBL] [Abstract][Full Text] [Related]
16. Fractional laser-mediated photodynamic therapy of high-risk basal cell carcinomas--a randomized clinical trial.
Haak CS; Togsverd-Bo K; Thaysen-Petersen D; Wulf HC; Paasch U; Anderson RR; Haedersdal M
Br J Dermatol; 2015 Jan; 172(1):215-22. PubMed ID: 24903544
[TBL] [Abstract][Full Text] [Related]
17. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours.
Calzavara-Pinton PG
J Photochem Photobiol B; 1995 Jul; 29(1):53-7. PubMed ID: 7472803
[TBL] [Abstract][Full Text] [Related]
18. Skin scrape cytology in the diagnosis of nodular basal cell carcinoma for treatment by photodynamic therapy.
Berner A; Soler A; Warloe T
Acta Derm Venereol; 1999 Mar; 79(2):147-9. PubMed ID: 10228637
[TBL] [Abstract][Full Text] [Related]
19. New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid.
Cappugi P; Mavilia L; Campolmi P; Reali EF; Mori M; Rossi R
J Chemother; 2004 Oct; 16(5):491-3. PubMed ID: 15565918
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.
Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K
Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
